MAIA Biotechnology Statistics
Total Valuation
MAIA has a market cap or net worth of $79.48 million. The enterprise value is $70.82 million.
Important Dates
The last earnings date was Monday, March 23, 2026, before market open.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MAIA has 60.67 million shares outstanding. The number of shares has increased by 44.68% in one year.
| Current Share Class | 60.67M |
| Shares Outstanding | 60.67M |
| Shares Change (YoY) | +44.68% |
| Shares Change (QoQ) | +12.02% |
| Owned by Insiders (%) | 8.27% |
| Owned by Institutions (%) | 4.16% |
| Float | 55.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 21.30 |
| P/TBV Ratio | 33.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66
| Current Ratio | 1.66 |
| Quick Ratio | 1.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -745.24% and return on invested capital (ROIC) is -504.74%.
| Return on Equity (ROE) | -745.24% |
| Return on Assets (ROA) | -152.76% |
| Return on Invested Capital (ROIC) | -504.74% |
| Return on Capital Employed (ROCE) | -627.41% |
| Weighted Average Cost of Capital (WACC) | 4.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.61% in the last 52 weeks. The beta is -0.02, so MAIA's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -20.61% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 32.71 |
| Average Volume (20 Days) | 1,324,879 |
Short Selling Information
The latest short interest is 1.82 million, so 2.99% of the outstanding shares have been sold short.
| Short Interest | 1.82M |
| Short Previous Month | 2.09M |
| Short % of Shares Out | 2.99% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 1.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.27M |
| Pretax Income | -22.40M |
| Net Income | -22.40M |
| EBITDA | n/a |
| EBIT | -24.27M |
| Earnings Per Share (EPS) | -$0.70 |
Full Income StatementBalance Sheet
The company has $8.66 million in cash and n/a in debt, with a net cash position of $8.66 million or $0.14 per share.
| Cash & Cash Equivalents | 8.66M |
| Total Debt | n/a |
| Net Cash | 8.66M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 2.38M |
| Book Value Per Share | 0.06 |
| Working Capital | 3.87M |
Full Balance SheetCash Flow
| Operating Cash Flow | -18.84M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
